Theralase Technologies Inc. V.TLT

Warrant extension implies 50-cents+ in two years

[newdaydawning]

I believe that target is imminently doable if we accomplish just two things:

1. We get BTD for NMIBC supported by good outcomes from the US trials;

2  We get promising results from the early human trials showing TLD-1433's efficacy and safety for the treatment of - and protection against - Covid-19 and every other nasty virus.

Considering today's SP, a move to 50 cents minimum implies a return of 177% over 2 years!

IMO, the upside potential for TLT far outweighs the downside risk.

[StevenBirch]

NDD,  I don't think most people are here for that kind of return. In fact I know I am not and would sell first thing Monday morning if I thought we would have to wait that long. I hope you are wrong.

[Pandora]

You're right, I agree. In the summer of 2019 it took about 5 months to go from 60c to 20c - now after a year and a half he's saying it will still take another two years to retrace to 50c. i.e. 3 1/2 years of waiting. Is that a good investment? Why wait 2 more years of nothing?

[Bunge]

Was going to write the same thing.  It was 60 cents 20 months ago. Made me feel ill thinking we should be happy with 50 cents in 2023.  

[CancerSlayer]

  A one-two punch of a BTD plus promising Covid-19 results in early human trials should pique Pharma interest, moving us much higher than 50 cents imo.   Not only do I believe in the science (I.e. no downside risk, just uncertain upside potential), I also believe that our trials should pick up steam as the North American grip on Covid finally tightens later this year with rising